$2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrants

BRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for cancer and autoimmune disease, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 3,105,591 shares of common stock (or pre-funded warrant in lieu thereof), series C warrants to purchase up to 3,105,591 shares of common stock and series D warrants to purchase up to 3,105,591 shares of common stock, at a combined purchase price of $0.805 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement. The series C warrants and the series D warrants will have an exercise price of $0.805 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the warrants (the “Stockholder Approval Date”). The series C warrants will expire six years from the later of the Stockholder Approval Date and the Effectiveness Date (as defined below) and the series D warrants will expire three years from the later of the Stockholder Approval Date and the Effectiveness Date. The private placement is expected to close on or about September 14, 2026, subject to the satisfaction of customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The gross proceeds from the offering are expected to be approximately $2.5 million, prior to deducting placement agent fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the series C warrants and the series D warrants, if fully exercised on a cash basis, will be approximately $5 million. No assurance can be given that any of the warrants will be exercised, or that the Company will receive cash proceeds from the exercise of the warrants. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.

The securities described above are being offered in a private placement exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the securities issued in the private placement and shares of common stock underlying the warrants may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement, the Company has agreed to file a registration statement covering the resale of the common stock (or the shares of common stock issuable upon exercise of the pre-funded warrant in lieu thereof) issued in the private placement and the shares of common stock issuable upon exercise of the warrants issued in the private placement (the date of effectiveness of such registration statement, the “Effectiveness Date”).

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Tempest Therapeutics

Tempest Therapeutics is a clinical-stage biotechnology company developing next-generation in vivo CAR-T therapies for cancer and autoimmune disease. Tempest’s lead product candidate, TPST-4003, combines a clinically supported dual-targeting CD19/BCMA CAR structure with an advanced CD7-targeting delivery system to support broad immune reset across multiple indications. Tempest envisions a world in which immune reset therapies bring safe, effective, and broadly accessible therapeutic options to patients in need. For additional information, visit Tempest’s website at https://www.tempesttx.com.

Forward-Looking Statements

This press release contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, concerning Tempest. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the management of Tempest, as well as assumptions made by, and information currently available to, management of Tempest. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “could”, “expect,” “anticipate,” “plan,” “likely,” “believe,” “estimate,” “project,” “intend,” “goal”, “suggest”, “target” and other similar expressions. All statements that are not historical facts are forward-looking statements, including but not limited to, statements regarding: the consummation of the offering and the satisfaction of customary closing conditions related to the private placement, the use of proceeds therefrom, the potential exercise of the warrants and the receipt of Stockholder Approval. All forward-looking statements in this press release are based on Tempest’s current expectations, estimates and projections about its industry as well as management’s current beliefs and expectations of future events only as of today and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to the market and other conditions, Tempest’s need for additional capital to fund its planned programs and operations and to continue to operate as a going concern; unexpected safety or efficacy data observed during preclinical or clinical trials; the possibility that results from prior clinical trials and preclinical studies may not necessarily be predictive of future results; past results may not be indicative of future results; clinical trial site activation or enrollment rates that are lower than expected; loss of key personnel; changes in expected or existing competition; changes in the regulatory environment; risks relating to volatility and uncertainty in the capital markets for biotechnology companies; and unexpected litigation or other disputes. These and other factors that may cause actual results to differ from those expressed or implied are discussed in greater detail in the “Risk Factors” section of Tempest’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 30, 2026, and in other documents filed by Tempest from time to time with the SEC. Except as required by applicable law, Tempest undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Tempest’s views as of any date subsequent to the date of this press release and should not be relied upon as prediction of future events. In light of the foregoing, investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Tempest.

Investor Contacts:

Sylvia Wheeler
Wheelhouse Life Science Advisors
swheeler@wheelhouselsa.com

Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com

Hong Kong, Sept. 11, 2026 (GLOBE NEWSWIRE) — Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leader in human resources (“HR”) and senior care solutions in Hong Kong, today announced that its Chief Executive Officer (“CEO”), Mr. Chan Chun Sing, has purchased 48,200 Class A ordinary shares of the Company in the open market.

Purchase Details

Mr. Chan acquired a total of 48,200 Class A ordinary shares of Click in the open market. All purchases were made at prevailing market prices, representing an aggregate investment of approximately US$49,900. For full details, please refer to the Form 4 filed with the U.S. Securities and Exchange Commission.

“These purchases reflect my personal commitment to the Company and to long-term value creation for shareholders,” said Mr. Chan, CEO of Click. “We remain focused on executing our plan in senior care, nursing, logistics and AI-powered HR solutions, while supporting the Company’s previously announced long-term strategy targeting approximately HK$500 million in annual revenue.”

The Company continues to focus on organic growth, strategic initiatives and operational performance, and remains open to additional mergers and acquisitions and cooperation MOUs to support its service offerings, market position and long-term strategy targeting approximately HK$500 million in annual revenue.

The Company expects to announce its annual results for the fiscal year ended June 30, 2026 in October 2026, in accordance with applicable reporting requirements. This press release does not contain financial results, forecasts or guidance.

About Click Holdings Limited (NASDAQ: CLIK)

Click Holdings Limited (NASDAQ: CLIK) is a Hong Kong-based leader in AI-powered human resources and senior care solutions. Through its proprietary platform, CLIK connects clients with a talent pool of over 25,000 professionals, serving nursing, logistics, and professional services sectors.

For more information, please visit https://clickholdings.com.hk.

Safe Harbor Statement

This press release contains forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov.

For enquiry, please contact:

Click Holdings Limited

Unit 1709-11, 17/F
Tower 2, The Gateway
Harbour City, Kowloon
Hong Kong
Email: jack.wong@jfy.hk
Phone: +852 2691 8200 

New Location Marks 17th Store in Denver Area

Black Rock Coffee Bar

Opening September 14 in Highlands Ranch
Opening September 14 in Highlands Ranch

Black Rock Coffee Bar

New Highlands Ranch Location Coming on September 14th
New Highlands Ranch Location Coming on September 14th

Scottsdale, AZ, Sept. 11, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee chain celebrated for its specialty coffees, teas, smoothies, and signature Fuel® energy drinks, is growing its footprint in Colorado with the opening of a new store in Highlands Ranch. 

The store, located at 9401 S University Blvd, will officially open its doors on Monday, September 14th. This opening marks Black Rock’s twenty-second Colorado location and reinforces the brand’s steady expansion across the region. Guests can enjoy the following specials during opening week: 

  • Monday, 9/14: Free 16oz Drinks 
  • Tuesday, 9/15: Buy One, Get One Free Drinks 
  • Wednesday, 9/16: 50% Off a Drink w/ Food Purchase 
  • Thursday, 9/17: Free Signature Grand Opening Sticker with purchase while supplies last 
  • Friday, 9/18: Free T-Shirt with purchase while supplies last 
  • Saturday, 9/19: $2 Off Any Size Drink 

“Each new store gives us the opportunity to become part of a new community, and we’re excited to continue growing in Colorado,” said Mark Davis, CEO of Black Rock Coffee Bar. “We’re thrilled to open new doors in Highlands Ranch and look forward to building relationships with local guests while bringing them the drinks, service, and energy that make Black Rock unique.”  

Guests can also take advantage of the Black Rock Rewards app, where every purchase—whether in-store, online, or through the app—earns “bolts” that can be redeemed for free beverages. Recent menu additions, like Black Rock’s protein-packed Egg Bites, are also included in the program. 

Black Rock Coffee Bar is beloved for its handcrafted beverages, including the Caramel Blondie, a sweet and creamy signature blend; the Mexican Mocha, a spicy twist with hints of vanilla, almond, and cinnamon; and the Jackhammer, a vanilla mocha with an extra double shot; as well as its in-house developed Fuel energy drink, customizable with over 20 fruit flavors.  These can be enjoyed alongside sweet and savory food items, including the recently launched Grilled Cheese and Pumpkin Blondie Cake Pop. For an extra kick of protein, guests can add Black Rock’s new Protein Cold Foam, Protein Boosted Milk or Protein Boost to their drinks. 

 

In addition to Black Rock menu staples, guests can enjoy limited-time offerings like the Pumpkin Spiced Latte, Pumpkin Blondie, and Pumpkin Spice Cookie Latte with Cookie Butter Cold Foam. The brand’s Fall Remix seasonal drinks are also now available, featuring the Caramel Apple Butter Shaken Espresso, Cinnamon Bun Latte, and Spellbound Berry Fuel, offering a mix of nostalgic and refreshing flavors. 

For more information, visit https://br.coffee/ and follow @blackrockcoffeebar on Facebook and Instagram, and @blackrockcoffeeofficial on TikTok for updates on new locations, promotions, and seasonal offerings. 

 

About Black Rock Coffee Bar  

Black Rock Coffee Bar is a national boutique coffee shop that is known for its premium roasted coffees, teas, smoothies and flavorful Fuel® energy drinks. Founded as a family owned and operated business in Oregon in 2008, Black Rock Coffee Bar has grown to over 200 retail locations in seven states. The Black Rock culture prides itself on not only being a positive force for the communities it serves, but also the team members that fuel their locations day in and day out. An important aspect of their team mission is to recognize those that go above and beyond by displaying the 4G’s of Black Rock – grit, growth, gratitude, and grace. For more information, visit https://br.coffee/.  

Attachments

CONTACT: Audrey Arbogast
Black Rock Coffee Bar
audrey.arbogast@havasred.com

McQueen & Queen Creek Rd Location to Celebrate Grand Opening on September 15th

Black Rock Coffee Bar

Opening September 15 in Chandler
Opening September 15 in Chandler

Black Rock Coffee Bar

New Chandler Location Coming on September 15th
New Chandler Location Coming on September 15th

Scottsdale, AZ, Sept. 11, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee company known for its specialty coffees, teas, smoothies, and popular Fuel® energy drinks, is expanding its footprint in the Valley with a new location opening this week. 

The store, located at 3103 S McQueen Rd, will officially celebrate its grand opening in Chandler on Tuesday, September 15th. Guests can enjoy $3 medium drinks all day, with the celebration continuing into the following day with a signature grand opening sticker giveaway. With this opening, Black Rock’s Arizona presence grows to 62 locations, underscoring the brand’s steady expansion throughout the Valley.  

“We’ve seen tremendous momentum across the valley, and we’re excited to build on that with our newest location in Chandler,” said Mark Davis, CEO of Black Rock Coffee Bar. “Our team is ready to welcome guests and make this location a go-to spot for their daily coffee, fuel, and connection.” 

Guests can also take advantage of the Black Rock Rewards app, where every purchase—whether in-store, online, or through the app—earns “bolts” that can be redeemed for free beverages. Recent menu additions, like Black Rock’s protein-packed Egg Bites, are also included in the program. 

Black Rock Coffee Bar is beloved for its handcrafted beverages, including the Caramel Blondie, a sweet and creamy signature blend; the Mexican Mocha, a spicy twist with hints of vanilla, almond, and cinnamon; and the Jackhammer, a vanilla mocha with an extra double shot; as well as its in-house developed Fuel energy drink, customizable with over 20 fruit flavors.  These can be enjoyed alongside sweet and savory food items, including the recently launched Grilled Cheese and Pumpkin Blondie Cake Pop. For an extra kick of protein, guests can add Black Rock’s new Protein Cold Foam, Protein Boosted Milk or Protein Boost to their drinks. 

 In addition to Black Rock menu staples, guests can enjoy limited-time offerings like the Pumpkin Spiced Latte, Pumpkin Blondie, and Pumpkin Spice Cookie Latte with Cookie Butter Cold Foam. The brand’s Fall Remix seasonal drinks are also now available, featuring the Caramel Apple Butter Shaken Espresso, Cinnamon Bun Latte, and Spellbound Berry Fuel, offering a mix of nostalgic and refreshing flavors.  

For more information, visit https://br.coffee/ and follow @blackrockcoffeebar on Facebook and Instagram, and @blackrockcoffeeofficial on TikTok for updates on new locations, promotions, and seasonal offerings. 

 

About Black Rock Coffee Bar  

Black Rock Coffee Bar is a national boutique coffee shop that is known for its premium roasted coffees, teas, smoothies and flavorful Fuel® energy drinks. Founded as a family owned and operated business in Oregon in 2008, Black Rock Coffee Bar has grown to over 200 retail locations in seven states. The Black Rock culture prides itself on not only being a positive force for the communities it serves, but also the team members that fuel their locations day in and day out. An important aspect of their team mission is to recognize those that go above and beyond by displaying the 4G’s of Black Rock – grit, growth, gratitude, and grace. For more information, visit https://br.coffee/.  

Attachments

CONTACT: Audrey Arbogast
Black Rock Coffee Bar
audrey.arbogast@havasred.com

Management to Hold One-on-One Meetings with Institutional Investors

SINGAPORE, Sept. 11, 2026 (GLOBE NEWSWIRE) — BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company specializing in proprietary cryptocurrency mining technologies and the manufacturing of cryptocurrency mining hardware, today announced that members of its management team will participate in the H.C. Wainwright 28th Annual Global Investment Conference, to be held September 14–16, 2026, at the Lotte New York Palace Hotel in New York City.

Management will also be available for one-on-one meetings with institutional investors during the conference. Investors interested in scheduling a meeting with the Company should contact their H.C. Wainwright representative or BGIN’s investor relations team at ir@bgin.com.

About BGIN BLOCKCHAIN LIMITED

BGIN BLOCKCHAIN LIMITED (NASDAQ: BGIN) is a digital asset technology company with proprietary cryptocurrency-mining technologies that leverages its experience in designing ASIC chips and mining machines to penetrate new cryptocurrency opportunities and execute on a long-term strategic focus on self-mining. BGIN’s mission is to make crypto mining accessible to all by developing innovative products tailored to various market needs, from beginners to large-scale industrial miners. BGIN designs and manufactures mining machines under its ICERIVER brand, providing customers with operational flexibility through advanced mining infrastructure and hosting services.

For more information, please visit: www.bgin.com or www.iceriver.io, or follow BGIN on X @Bgin_Blockchain and LinkedIn @BGIN, and follow ICERIVER® on X @IceRiverMiner.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” “target,” “project,” “potential,” “seek,” “may,” “should,” “could,” “would,” and similar expressions or the negative thereof. Statements that are not historical facts, including but not limited to statements regarding the Company’s participation in investor conferences, management’s availability for meetings with institutional investors, and the Company’s strategic plans and objectives, are forward-looking statements. Although BGIN believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and BGIN cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results set forth in BGIN’s filings with the U.S. Securities and Exchange Commission (the “SEC”). Additional factors are discussed in BGIN’s filings with the SEC, which are available for review at www.sec.gov. All information provided in this press release is as of the date of this press release, and BGIN does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

BGIN BLOCKCHAIN LIMITED

Investor Relations
Jennifer Jiang
ir@bgin.com

Media Relations
Ray Xie
pr@bgin.com

VANCOUVER, British Columbia, Sept. 11, 2026 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) announces the completion of an initial geological reconnaissance programme across its critical minerals portfolio in northern Bahia, southern Bahia and Ceará, Brazil.

Together, the three land packages cover approximately 123,900 hectares within established and emerging critical minerals provinces. The reconnaissance programme confirmed geological settings supporting further evaluation for Cu-Ni-Co and rare earth elements (“REE”) in northern Bahia and lithium exploration in southern Bahia and Ceará.

Highlights

  • Initial geological reconnaissance confirmed geological settings relevant to Cu-Ni-Co and REE exploration in northern Bahia and lithium exploration in southern Bahia and Ceará.
  • In northern Bahia, field observations identified mafic rocks for Cu-Ni-Co evaluation and magnetic, potassium-rich rocks within the Itiúba Syenitic Massif, a geological setting considered favourable for REE-Nb-Zr-Y exploration.
  • Coarse-grained pegmatites were identified within selected tenements in southern Bahia and Ceará, providing priority areas for follow-up lithium exploration.
  • GoldHaven’s three Brazilian land packages cover approximately 123,900 hectares within established and emerging critical minerals provinces.
  • Rock samples have been submitted for laboratory analysis, with results to be used to refine exploration priorities and guide focused follow-up work.

CEO Commentary

Rob Birmingham, President and CEO of GoldHaven, commented:

“This programme accomplished exactly what we set out to do — rapidly evaluate a large land position and identify the geological environments that warrant further investment. Across approximately 123,900 hectares, we have identified areas for focused Cu-Ni-Co and rare earth evaluation in northern Bahia, together with coarse-grained pegmatites warranting follow-up for lithium potential in southern Bahia and Ceará.”

“With samples now at the laboratory, the results will help us prioritize the strongest opportunities and determine where we focus our next phase of exploration.”

Geological Reconnaissance Programme

The reconnaissance programme was designed to test the initial geological interpretations across GoldHaven’s Brazilian critical minerals portfolio, confirm the occurrence of relevant geological environments and establish an initial order of priority for follow-up exploration.

Given the scale of the land packages, an important objective was to rapidly screen the properties, deprioritize areas considered less prospective and concentrate future geological work and exploration expenditure on the most prospective areas.

Field activities included geological reconnaissance, verification of regional geological interpretations, examination of available outcrops and the collection of representative rock samples. Samples have been submitted for laboratory analysis, with results pending.

Figure 1
Figure 1. Location map of the GoldHaven tenements

Northern Bahia – Cu-Ni-Co and Rare Earth Targets

GoldHaven’s northern Bahia land package covers approximately 41,400 hectares and supports the evaluation of two distinct exploration concepts: Cu-Ni-Co and REE-Nb-Zr-Y.

The properties cover portions of the Caraiba granulitic terrain, including areas containing mafic to locally ultramafic rocks, and the Itiúba Syenitic Massif, where magnetic and potassium-rich syenitic rocks provide a favourable geological setting for REE-Nb-Zr-Y exploration.

The Cu-Ni-Co concept is associated with mafic and ultramafic rocks. Tenements 871.601/2024, 871.578/2024, 871.590/2024 and 871.597/2024 have been selected for initial follow-up based on the recognition of mafic rocks during fieldwork, including bedrock exposures. Laboratory analysis and focused geological mapping will be used to assess the composition and distribution of these rocks.

The REE-Nb-Zr-Y concept is associated with syenitic and other alkaline to felsic rocks. Tenements 871.596/2024, 871.593/2024, 871.595/2024 and 871.594/2024 have been selected for initial follow-up based on their position within the Itiúba Syenitic Massif and the occurrence of magnetic and potassium-rich rocks. Laboratory analysis will be required to assess their geochemical characteristics and relevance to REE-Nb-Zr-Y exploration.

The field programme included the collection of 13 rock samples.

Figure 2
Figure 2. Northern Bahia Project showing GoldHaven’s tenements and the distribution of rock types identified during the initial geological reconnaissance programme.

Southern Bahia – Coarse-Grained Pegmatite Occurrences

GoldHaven’s southern Bahia land package covers approximately 30,700 hectares within a geological environment relevant to lithium exploration.

Field reconnaissance confirmed the presence of coarse-grained pegmatites within tenements 871.606/2024 and 871.607/2024, which have been selected for initial LCT follow-up. The properties are located within a regional geological environment containing paragneisses, metasedimentary rocks, muscovite-bearing rocks and granitic intrusions. Historical occurrences of beryl, niobium and gem-bearing pegmatites are also reported in the region.

The pegmatites observed within the two tenements occur within metasedimentary host rocks. Follow-up work will include geochemical analysis, mineralogical studies and more detailed pegmatite mapping.

Tenement 871.610/2024 remains a secondary follow-up area based on pegmatitic and muscovite-rich altered rocks recognized during the reconnaissance programme.

The presence of coarse-grained pegmatites alone does not establish LCT fertility. Laboratory analysis and mineralogical studies are required to determine their composition and exploration significance.

Figure 3
Figure 3. Southern Bahia Project showing GoldHaven’s tenements and the distribution of rock types identified during the initial geological reconnaissance programme.

Figure 4
Figure 4. Coarse pegmatites identified in Southern Bahia

Ceará (Iguatu) – Pegmatite Occurrences

GoldHaven’s Ceará land package covers approximately 51,800 hectares within and near the Solonópole Pegmatite Sub province, a geological setting relevant to the evaluation of LCT pegmatites.

Field reconnaissance confirmed the presence of coarse-grained pegmatites within tenements 801.099/2023, 801.119/2023 and 801.115/2023, which have been selected for initial LCT follow-up. The properties are located mainly within the Acopiara Complex and near the Solonópole Pegmatite Sub province.

The pegmatites observed within these three tenements locally contain muscovite and occur in granitic and metasedimentary geological environments. Follow-up work will include geochemical analysis, mineralogical studies and more detailed mapping.

Pegmatite veins and outcrops were also identified within tenements 801.102/2023, 801.108/2023, 801.120/2023 and 801.117/2023. Their relative priority will be assessed following receipt and interpretation of the analytical results.

The field programme included the collection of 19 rock samples.

Figure 5
Figure 5. Ceará Project showing GoldHaven’s tenements and the distribution of rock types identified during the initial geological reconnaissance programme.

Figure 6
Figure 6. Coarse pegmatite outcrop, Ceará tenements

Samples at Laboratory and Next Steps

Rock samples collected during the reconnaissance programme have been submitted for laboratory analysis. Results will be used to refine exploration priorities and guide follow-up work.

The analytical programme includes:

  • Cu, Ni, Co, Cr, V, Sc, Au, Ag and platinum-group elements for mafic and ultramafic rocks;
  • REE, Nb, Ta, Zr, Hf, Y, Th, U, Ga and relevant major elements for syenitic and felsic rocks; and
  • Li, Cs, Rb, Ta, Nb, Sn, Be, B, Ga, Ge, W and complete REE analysis for pegmatites.

Once received, the analytical results will be integrated with field observations and regional geological information. Interpretation will consider multi-element associations and geological context rather than individual anomalous values.

The results will be used to refine the current exploration priorities and determine where focused geological mapping, mineralogical studies and additional sampling are warranted. In northern Bahia, follow-up work may assess the distribution of mafic to ultramafic rocks and selected portions of the Itiúba Syenitic Massif. In southern Bahia and Ceará, follow-up work may focus on the composition, distribution and geological controls of the identified pegmatites.

GoldHaven will provide a further update once the analytical results have been received and interpreted.

Qualified Person

The scientific and technical information contained in this news release has been reviewed and approved by Jonathan Victor Hill, B.Sc. (Hons), FAusIMM, a Qualified Person as defined by National Instrument 43-101 and Country Manager of GoldHaven Resources Corp. Mr. Hill is not independent of the Company.

Investor Awareness

GoldHaven has engaged PanAm Marketing Inc. (“PanAm”) to provide digital investor awareness and marketing services, including digital advertising, content development and coordination with third-party publishers and content creators across online advertising networks, financial and investment websites, social media platforms and email newsletters. The engagement is for an initial three-month term commencing September 11th, 2026 and ending December 11th 2026, for a total campaign budget of $300,000 payable in cash. No securities, options, warrants or performance-based compensation are payable. PanAm is arm’s length to the Company and, to the Company’s knowledge, neither PanAm nor its principals currently hold any securities of GoldHaven. PanAm’s contact information is: Jeff Leslie, 5728 East Blvd., Vancouver, BC V6M 4M4; accounts@panam.marketing; 780-257-4680.

About GoldHaven Resources Corp.

GoldHaven Resources Corp. is a Canadian junior exploration company focused on advancing highly prospective mineral projects in North and South America. The Company’s flagship asset is the district-scale Magno Project in the Cassiar District of northern British Columbia. GoldHaven also owns the Three Guardsmen copper-gold project in British Columbia and the Copeçal Gold Project in Mato Grosso, Brazil. In addition, the Company holds a portfolio of critical mineral projects in Brazil.

On Behalf of the Board of Directors

Rob Birmingham, Chief Executive Officer

For further information, please contact:
Rob Birmingham, CEO
www.GoldHavenresources.com
info@goldhavenresources.com
Office Direct: (604) 629-8254

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE- Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

This news release contains forward-looking statements and forward-looking information (collectively, “forward looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included herein including, without limitation, those listed below under the heading “Forward-Looking Statements in This News Release” are forward-looking statements. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: “believes”, “will”, “expects”, “anticipates”, “intends”, “estimates”, “plans”, “may”, “should”, “potential”, “scheduled”, or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that there will be investor interest in future financings, market fundamentals will result in sustained precious metals demand and prices, the receipt of any necessary permits, licenses and regulatory approvals in connection with the future exploration and development of any future projects in a timely manner, the availability of financing on suitable terms for exploration and development of future projects and the Company’s ability to comply with environmental, health and safety laws.

The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors, including, operating and technical difficulties in connection with mineral exploration and development activities, actual results of exploration activities, the estimation or realization of mineral reserves and mineral resources, the inability of the Company to obtain the necessary financing required to conduct its business and affairs, as currently contemplated, the inability of the Company to enter into definitive agreements in respect of possible Letters of Intent, the timing and amount of estimated future production, the costs of production, capital expenditures, the costs and timing of the development of new deposits, requirements for additional capital, future prices of precious metals, changes in general economic conditions, changes in the financial markets and in the demand and market price for commodities, lack of investor interest in future financings, accidents, labour disputes and other risks of the mining industry, delays in obtaining governmental approvals, permits or financing or in the completion of development or construction activities, changes in laws, regulations and policies affecting mining operations, title disputes, the inability of the Company to obtain any necessary permits, consents, approvals or authorizations, including by the Exchange, the timing and possible outcome of any pending litigation, environmental issues and liabilities, and risks related to joint venture operations, and other risks and uncertainties disclosed in the Company’s latest interim Management’s Discussion and Analysis and filed with certain securities commissions in Canada. All of the Company’s Canadian public disclosure filings may be accessed via www.sedarplus.ca and readers are urged to review these materials.

Readers are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to update any of the forward-looking statements in this news release or incorporated by reference herein, except as otherwise required by law.

Forward-Looking Statements in This News Release

The following statements in this news release constitute forward-looking information:

  • The expectation that laboratory analysis of the rock samples collected during the reconnaissance programme will be used to refine exploration priorities and guide follow-up work
  • GoldHaven’s plans for follow-up work in northern Bahia, including geological mapping and laboratory analysis to assess the composition and distribution of mafic to ultramafic rocks and rocks within the Itiúba Syenitic Massif
  • GoldHaven’s plans for follow-up work in southern Bahia and Ceará, including geochemical analysis, mineralogical studies and more detailed pegmatite mapping
  • The expectation that analytical results will be integrated with field observations and regional geological information to determine where focused geological mapping, mineralogical studies and additional sampling are warranted
  • GoldHaven’s intention to provide a further update once the analytical results have been received and interpreted

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/a9ac10ec-a6a9-4aa0-a7d0-fd17aae54d33

https://www.globenewswire.com/NewsRoom/AttachmentNg/342df922-454d-4603-b805-9428f76b95de

https://www.globenewswire.com/NewsRoom/AttachmentNg/78d70fa5-fb8a-41f5-9ee1-eb39693afbff

https://www.globenewswire.com/NewsRoom/AttachmentNg/c9badab4-4784-4953-818f-a6f4440b0c1f

https://www.globenewswire.com/NewsRoom/AttachmentNg/3375ad51-32f4-49c4-aabb-cec6c961fd24

https://www.globenewswire.com/NewsRoom/AttachmentNg/84d046e4-0573-4bc1-a8e9-df5eabe398c4

Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder (“AUD”), today announced the enrollment of the first patients with Alcohol Use Disorder (“AUD”) in its ongoing clinical trial evaluating CMND-100, the Company’s proprietary psychedelic-based treatment candidate for AUD.

The first two patients were enrolled at Hadassah Medical Center in Jerusalem, Israel, marking the first time CMND-100 is administered to a patient with AUD. To date, the Company has evaluated CMND-100 at multiple doses in healthy participants as part of its clinical development program.

“Our enrollment trajectory continues to build positively and treating the first Alcohol Use Disorder patients with CMND‑100 represents a major step forward,” said Adi Zuloff‑Shani, Ph.D., Chief Executive Officer of Clearmind. “This achievement highlights the growing momentum behind the program and positions us well as we progress toward key clinical milestones that we believe can drive meaningful value for shareholders.

The clinical trial is designed to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of CMND-100 in patients with Alcohol Use Disorder.

About Clearmind Medicine Inc.

Clearmind is a clinical-stage neuroplastogens pharmaceutical biotech company focused on the discovery and development of non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements.

The Company’s intellectual portfolio currently consists of nineteen patent families, including 32 granted patents. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Shares of Clearmind are listed for trading on Nasdaq under the symbol “CMND.”

For further information, visit: https://www.clearmindmedicine.com or contact:

Investor Relations
invest@clearmindmedicine.com
www.Clearmindmedicine.com

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the anticipated progress of the CMND-100 clinical trial, the achievement of future clinical milestones, the potential safety, tolerability, pharmacokinetic and efficacy results of CMND-100, the continued enrollment of patients in the trial, the development and commercialization potential of CMND-100, and the potential value that the program may create for shareholders. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report on Form 20-F for the fiscal year ended October 31, 2025 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Clearmind is not responsible for the contents of third-party websites.

  • Future registration-directed clinical development of efti is intended to focus on head and neck squamous cell carcinoma (HNSCC) in patients with negative PD-L1 expression (Combined Positive Score (CPS) < 1) and the neoadjuvant setting of soft tissue sarcoma (STS).
  • Root cause analysis following the discontinuation of TACTI-004 has identified subtle analytical differences between efti manufactured at 200 L scale and efti manufactured at 2,000 L scale. A new manufacturing run of efti at 200 L scale has been contracted.
  • This development focus reflects a staged risk/benefit approach consistent with prior interactions with the U.S. Food and Drug Administration (FDA), Orphan Drug Designation granted for STS in April 2026, and Fast Track designation for HNSCC.
  • Preparations for the next clinical trials have commenced, with study start targeted for 2H CY2027, subject to final decisions on trial design, regulatory interactions, manufacturing timelines, partnering and resources.

SYDNEY, AUSTRALIA, Sept. 11, 2026 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today provides an update on its development strategy for eftilagimod alfa (“efti”).

Update on Root Cause Analysis
Following the early discontinuation of the TACTI-004 study, Immutep has been conducting a detailed root cause analysis covering clinical, pharmacological and manufacturing aspects. This ongoing root cause analysis has identified structural differences between the efti used in TACTI-004 and the efti used in earlier successful clinical studies. These differences (e.g. a subtle difference in N-glycan structure) are considered potentially relevant given the markedly different immune activation profile observed in TACTI-004 compared to previous trials and the unexpected clinical outcome of the study.

Based on the currently available data from the Root Cause Analysis to date, Immutep believes that the unexpected outcome of TACTI-004 cannot be explained by clinical factors (e.g. suboptimal protocol, substantial imbalance between treatment arms or safety findings) or trial execution factors (e.g. invalid randomisation pattern or general clinical trial conduct). The Company will provide a further update on completion of the root cause analysis.

New Manufacturing Run
Based on the findings from the root cause analysis to date, Immutep has contracted a manufacturing run of efti at 200 L scale. Ten GMP batches of efti have previously been manufactured at 200 L scale and used in successful Phase I and Phase II clinical studies of efti, including TACTI-mel, TACTI-002 and INSIGHT-003. In contrast, TACTI-004 was conducted exclusively with efti manufactured at 2,000 L scale.

Future Clinical Development Focus
Immutep currently intends to focus the registration-directed clinical development of efti on:

  • HNSCC in patients with CPS < 1 — based on clinical efficacy data, including mature overall survival data, in a patient population with high unmet need and limited approved treatment options, and for which efti has received Fast Track designation and FDA feedback that the Company considers constructive; and
  • the neoadjuvant setting of STS — based on positive Phase II data, including achievement of the primary endpoint, and for which efti received Orphan Drug Designation from the FDA in April 2026.

This focus reflects the compelling clinical data generated to date, the Company’s interactions with the FDA, regulatory designations obtained, unmet medical need and substantial market potential in these indications.

Preparations for the next clinical trials have commenced. Subject to final decisions on strategy and trial design, regulatory interactions, manufacturing timelines, partnering and resources, Immutep is targeting study start during 2H CY2027.

Immutep’s licensing partner, Dr. Reddy’s Laboratories (“DRL”), has been consulted on and is supportive of this approach. The Company is also in preliminary discussions with other parties regarding the proposed development pathway.

Immutep CEO, Marc Voigt, said: “Based on the totality of evidence generated with efti, we believe there is a scientifically and clinically justified path to continue its development. This includes clinical and translational data across multiple tumour types, consistent evidence of immune activation, encouraging results in soft tissue sarcoma and head and neck cancer with CPS < 1, and constructive regulatory interactions. At the same time, we fully recognise the significance of the TACTI-004 outcome. Our root cause analysis remains ongoing, including further investigation of smaller differences identified between product batches. We intend to apply these learnings rigorously and focus future potential development on settings where the clinical evidence, biological rationale, time-to-market and unmet medical need are most compelling.”

Other Programs
Immutep’s LAG-3 portfolio extends beyond efti. Development of IMP761, the Company’s agonist anti-LAG-3 antibody for autoimmune disease, continues in line with previously disclosed plans.

About Eftilagimod Alfa (Efti)
Efti is a novel immunotherapy that directly activates antigen-presenting cells or APCs (e.g. dendritic cells, monocytes) via the MHC Class II pathway to fight cancer. As an MHC Class II agonist, its activation of APCs engages the adaptive and innate immune system to initiate a broad anti-cancer immune response. This includes priming and activating cytotoxic T cells as well as generating important co-stimulatory signals and cytokines that further boost the immune system’s ability to combat cancer.

Efti’s favourable safety profile has enabled various combinations, including with anti-PD-[L]1 immunotherapy, radiotherapy, and/or chemotherapy. Efti has received Fast Track designation in 1st line HNSCC and in 1st line NSCLC, and Orphan Drug Designation in STS, from the United States Food and Drug Administration (FDA).

About Immutep
Immutep is a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune diseases. The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and its diversified product portfolio harnesses LAG-3’s ability to stimulate or suppress the immune response. Immutep is dedicated to leveraging its expertise to bring innovative treatment options to patients in need and to maximise value for shareholders. For more information, please visit www.immutep.com.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding anticipated clinical development, regulatory progress and potential benefits of eftilagimod alfa (efti) and IMP761. These forward-looking statements are based on current expectations, estimates and projections, and involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in such statements.

Factors that could cause actual results to differ materially include risks associated with clinical trial outcomes, the ongoing root cause analysis, manufacturing, the ability to reach agreement with regulators on trial design and registrational pathways, the outcome of partnering discussions, and the Company’s ability to obtain additional funding and to advance its product candidates. Additional risks are described in the Company’s most recent Annual Report on Form 20-F and subsequent filings with the U.S. Securities and Exchange Commission and in announcements lodged with the ASX. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. Immutep undertakes no obligation to update or revise such statements, except as required by applicable law.

Disclaimer
This announcement has been prepared for informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, securities in any jurisdiction.

Australian Investors/Media:
Eleanor Pearson, Sodali & Co.
+61 2 9066 4071; eleanor.pearson@sodali.com

U.S. Investors/Media:
Matthew Beck, astr partners
+1 (917) 415 1750; matthew.beck@astrpartners.com

OMAHA, Neb., Sept. 11, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus” or the “Company”), a leading self-custodial finance and payments platform, today announced select metrics for the month of August 2026 in connection with its Web3 and Payment Processing services.

“August was an encouraging month across both sides of our business,” said James Gernetzke, CFO of Exodus. “Our Web3 exchange volumes increased approximately 20% from July as monthly active users remained relatively stable. While we remain cautious about drawing conclusions from one month of improved activity, we are encouraged by the direction of exchange volumes on our platform.”

“Transaction activity in our payments business also continued to grow, with gross transaction volume increasing approximately 6% from July and nearly 18% from June. Importantly, this growth is occurring before the benefit of several operational initiatives currently underway. We also continue to make progress on the payments infrastructure initiatives discussed during our August earnings call while integrating Monavate and executing against our broader cost-reduction initiatives.”

Web3 Services

Exchange provider processed volume was $376.8 million for the month of August 2026, of which 23% originated from the Company’s XO Swap partners. This compares with $314.8 million exchange provider processed volume in July 2026, of which 23% originated from the Company’s XO Swap partners.

Monthly Active Users (MAUs) were 1.4 million as of August 31, 2026, compared to 1.4 million as of July 31, 2026.

Payment Processing Services

Gross transaction volume was $356.8 million for the month of August 2026, compared to $338.0 million in gross transaction volume for the month of July 2026. Gross transaction volume is calculated by converting total monthly transaction volume from British Pounds (GBP) to U.S. Dollars using the average currency conversion rate of 1 GBP to 1.35 USD for August and 1 GBP to 1.34 USD for July.

Monthly Active Cards were 757.9 thousand as of August 31, 2026, compared to 783.6 thousand as of July 31, 2026. Monthly Active Cards represents the total number of unique payment cards issued on behalf of enterprise customers that made transactions during the applicable month.

About Exodus

Founded in 2015, Exodus Movement, Inc. (NYSE American: EXOD) is pioneering self-custodial finance by giving people the tools to earn rewards, spend, manage, and swap digital assets across borders, all without giving up control. Exodus serves millions of users through its products built on a simple principle: your money should be yours.

Exodus also powers crypto infrastructure and card/payment services for enterprise platforms serving millions of users through its enterprise product suite. Headquartered in Omaha, Nebraska, Exodus is financial software where ownership is the default. For more information, visit exodus.com.

Investor Contact

investors@exodus.com

Media Contact

Aubrey Strobel/Elena Nisonoff, Halcyon Communications
exodus@halcyonpr.xyz

Disclosure Information

Exodus uses the following as means of disclosing material nonpublic information and for complying with disclosure obligations under Regulation FD: websites exodus.com/investors and exodus.com; press releases; public videos, calls, and webcasts; and social media: X (@exodus and JP Richardson’s feed @jprichardson), Facebook, LinkedIn, and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements are based on our beliefs and assumptions and on information currently available to us as of the date hereof. In some cases, you can identify forward-looking statements by the following words: “will,” “expect,” “would,” “should,” “intend,” “believe,” “likely,” “believes,” “views”, “estimates”, or other comparable terminology.

Forward-looking statements in this document include, but are not limited to, management statements regarding management’s confidence in our products, services, business trajectory and plans, expectations regarding demand for our products, and volatility and trading volumes of digital asset markets. Such forward-looking statements involve a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those expressed or implied by our forward-looking statements. Such factors include those set forth in “Item 1. Business” and “Item 1A. Risk Factors” of Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 11, 2026, the Q2 2026 Form 10-Q as well as in our other reports filed with the SEC from time to time.

All forward-looking statements are expressly qualified in their entirety by such cautionary statements. Readers are cautioned not to place undue reliance on such forward-looking statements. Except as required by law, we undertake no obligation to update or revise any forward-looking statements that have been made to reflect events or circumstances that arise after the date made or to reflect the occurrence of unanticipated events.

Revenue Grew to $97.7M, up 20.8% YoY

Gross margin expansion of 609 basis points

Reaffirms FY26 Guidance for Revenue and Adjusted EBITDA

Announces Paige Thomas as Chief Executive Officer and President and Teri Bariquit as Chair of the Board

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) — Rent the Runway, Inc. (“Rent the Runway” or “RTR”) (NASDAQ: RENT), the company transforming the way women get dressed, today reported financial results for the fiscal quarter ended July 31, 2026.

Second quarter results reflect continued execution against our plan, with total revenue of $97.7 million, up 20.8% YoY. Net loss was $(12.9) million, or (13.2)% of revenue, compared to $(26.4) million, or (32.6)% of revenue, in the second quarter of fiscal year 2025. Adjusted EBITDA was $12.6 million, or 12.9% of revenue, compared to $3.6 million, or 4.4% of revenue, in the second quarter of fiscal year 2025, driven by gross margin expansion of 609 basis points and disciplined control of operating expenses. We also continued to see growth in our add-on business, with add-on bookings increasing 81% year-over-year in Q2 and 33% of subscribers using an add-on during the quarter, up from 29% a year ago, driven primarily by higher subscriber engagement with our assortment and membership flexibility.

A key focus in 2026 remains on Discovery, and this quarter we completed the rollout of AI-powered outfits generation to all customers, delivering on the commitment we set out at the start of the fiscal year. We also concentrated our resources on the core rental and selling businesses, stepping back from several pilots and smaller initiatives to focus on the experience our customers value most.

Rent the Runway also announced today that Paige Thomas has been appointed Chief Executive Officer and President and member of the Board of Directors, effective September 14, 2026, succeeding Teri Bariquit, who has served as Interim CEO and President since May 2026. Ms. Bariquit has been appointed non-executive Chair of the Board of Directors, effective the same date, and will work closely with Ms. Thomas to support the transition. Dhiren Fonseca, will step down as Executive Chairman, and continue as a member of the Board. The Board of Directors thanks and acknowledges Mr. Fonseca for his leadership during the period of transition.

Ms. Thomas brings over 30 years of retail leadership to the role. She joined Rent the Runway as Chief Commercial Officer in June 2026, and previously served as Chief Merchant and Product Innovation Officer at Signet Jewelers, President and CEO of Saks OFF 5TH, and spent more than a decade at Nordstrom, including five years leading Nordstrom Rack.

“Rent the Runway is operating from a focused foundation, with a core rental business that continues to grow and a customer who is telling us what she values most,” said Teri Bariquit, Interim CEO and President of Rent the Runway. “This quarter we concentrated our resources on that core, delivered capabilities against the discovery experience we committed to at the start of the year, and began building a 2027 plan centered on transforming the business. I want to thank Dhiren for his leadership as Executive Chairman through this transition, and I am confident in the company Paige is stepping into.”

“I’m focused on listening to our customer and making every decision through her lens, doubling down on fashion and what makes this fashion service platform unique, while executing with operational excellence,” said Paige Thomas, CEO of Rent the Runway. “This is not a new direction—it’s an acceleration of the strong foundation the team has built. The path is clear, and I’ve never been more excited to lead the team forward.”

Recent Business Highlights

  • AI-Powered Outfits Generation Now Live to All Customers: In May 2026, we piloted outfits generation, and by the end of June the experience was live to all customers. Customers can now discover complete looks rather than individual items, making it easier to imagine what to wear together. Engagement with the feature in our app is running approximately 35% and during the pilot, customers with the experience added items to their bag approximately 12% more often than those without it.
  • Using AI to Help Customers See Themselves in the Product: In August 2026, we rolled out avatars within the outfits experience to all customers, so they can see recommended looks on a variety of figures. We also began piloting virtual try-on tools, designed to show a customer how a specific item will look on them before renting or buying.
  • Sharpened Focus on the Core Business: We concentrated our resources on our rental and selling offerings this quarter. We paused the online marketplace pilot until it can be fully integrated with the core rental experience, we paused on-site advertising and monetization to prioritize a premium experience, and we are no longer pursuing new B2B dry cleaning business opportunities while continuing to serve our existing partner. Those resources are moving to the parts of the business our customer values most, including Reserve, which carries our strongest satisfaction scores.

“Second quarter results were strong with revenues that reflect an all-time high for the company and profit margin expansion that is driven by our operating discipline and highlights how we intend to run the business,” said Dave Loretta, Interim Chief Financial Officer and Treasurer of Rent the Runway. “We remain committed to strengthening our liquidity position with the improved free cash flow in the first half and additional funding support from our investor group.”

Second Quarter 2026 Key Metrics and Financial Highlights

  • Revenue was $97.7 million, a 20.8% increase year-over-year from $80.9 million in the second quarter of fiscal year 2025.
  • 140,826 ending Active Subscribers, representing a change of (3.8)% from 146,373 at the end of the second quarter of fiscal year 2025.
  • 148,259 Average Active Subscribers, representing an increase of 1.0% from 146,765 at the end of the second quarter of fiscal year 2025.
  • 186,019 ending Total Subscribers, representing an increase of 0.5% from 185,102 at the end of the second quarter of fiscal year 2025.
  • Gross Profit was $35.3 million, representing an increase of 45.3% from $24.3 million in the second quarter of fiscal year 2025. Gross Margin was 36.1%, as compared to 30.0% in the second quarter of fiscal year 2025.
  • Net Loss was $(12.9) million, as compared to $(26.4) million in the second quarter of fiscal year 2025. Net Loss as a percentage of revenue was (13.2)%, as compared to (32.6)% in the second quarter of fiscal year 2025.
  • Adjusted EBITDA was $12.6 million, as compared to $3.6 million in the second quarter of fiscal year 2025. Adjusted EBITDA Margin was 12.9%, as compared to 4.4% in the second quarter of fiscal year 2025.
  • Net cash (used in) provided by operating activities was $(5.0) million, as compared to $(2.2) million in the second quarter of fiscal year 2025.
  • Net cash used in investing activities was $(16.6) million, as compared to $(30.7) million in the second quarter of fiscal year 2025.
  • Cash and Cash Equivalents was $29.0 million, as compared to $43.6 million in the second quarter of fiscal year 2025.

Outlook

For the fiscal third quarter of 2026, Rent the Runway expects:

  • Revenue of between $87 million and $90 million
  • Adjusted EBITDA Margin1 of between negative 3% and negative 6%

For fiscal year 2026, Rent the Runway expects:

  • Reaffirming Double-Digit Revenue Growth versus fiscal year 2025, led primarily by continued product and inventory experience improvements.
  • Reaffirming Adjusted EBITDA Margin2 of between 4% and 7%
  • Updating Rental Product Acquired3 in the range of $53-55 million versus $74.9 million in fiscal year 2025.

There are unknowns around the economy, such as fuel surcharges, tariffs, and other macroeconomic developments, which are not incorporated into our expectations and that can materially affect actual results for fiscal year 2026 versus our current expectations. Our outlook is based on current conditions and assumptions and does not contemplate material deterioration, including volatility in these factors or from our decision to pass on fuel surcharges to customers; accordingly, actual results may differ materially if such conditions change.

1 Represents a non-GAAP financial measure. As more fully described in the Non-GAAP Financial Measures section of this release, a reconciliation of Adjusted EBITDA Margin for the third quarter of fiscal year 2026 is not available without unreasonable efforts.
2 Represents a non-GAAP financial measure. As more fully described in the Non-GAAP Financial Measures section of this release, a reconciliation of Adjusted EBITDA Margin for fiscal year 2026 is not available without unreasonable efforts.
3 Purchases of Rental Product as presented on the Consolidated Statement of Cash Flows may vary from Rental Product Acquired due to timing of payments for rental product. Rental Product Acquired reflects the cost of owned rental product received in the period.

Earnings Presentation, Conference Call and Webcast

Rent the Runway will host a conference call and webcast to discuss its second quarter 2026 financial results and provide a business update today, September 11, 2026 at 8:30 am ET.

The financial results and live webcast will be accessible through the Investor Relations section of Rent the Runway’s website at https://investors.renttherunway.com/ under the “Events” section. To access the call through a conference line, dial 1-877-407-3982 (in the U.S.) or 1-201-493-6780 (international callers).

A replay of the conference call will be posted shortly after the call and will be available for at least fourteen days. To access the replay, dial 1-844-512-2921 (in the U.S.) or 1-412-317-6671 (international callers). The access code for the replay is 13761570.

About Rent the Runway, Inc.

Founded in 2009, Rent the Runway is disrupting the trillion-dollar fashion industry and changing the way women get dressed through the Closet in the Cloud. RTR’s mission has remained the same since its founding: powering women to feel their best every day. Through RTR, customers can subscribe, rent items a-la-carte and shop resale from hundreds of designer brands. The Closet in the Cloud offers a wide assortment of millions of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear and ski wear. RTR has built a two-sided discovery engine, which connects deeply engaged customers and differentiated brand partners on a powerful platform built around its brand, data, logistics and technology. RTR has been named to CNBC’s “Disruptor 50” five times in ten years, and has been placed on Fast Company’s Most Innovative Companies list four times.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. These statements include, but are not limited to, guidance and underlying assumptions for the third fiscal quarter of 2026 and the fiscal year 2026, and statements regarding the anticipated success of our CEO and Board chair transitions, our sharpened business strategies and priorities, the impact of potential product and customer experience improvements, the impact and volume of our new inventory, the success of our AI investments and initiatives, and our position for sustained growth. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements because they contain words such as “aim,” “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “toward,” “will,” or “would,” or the negative of these words or other similar terms or expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved, if at all. Forward-looking statements are based on information available at the time those statements are made and were based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These risks and uncertainties include our ability to drive future growth or manage our growth effectively; the highly competitive and rapidly changing nature of the global fashion industry; risks related to the macroeconomic environment, including war in the Middle East and fuel surcharges; changes in global trade policies, tariffs, and other measures that could restrict international trade; our ability to cost-effectively grow our customer base; any failure to attract or retain customers; our ability to accurately forecast customer demand, acquire and manage our offerings effectively and plan for future expenses; risks arising from the restructuring of our operations; our reliance on the effective operation of proprietary technology systems and software as well as those of third-party vendors and service providers; risks related to shipping, logistics and our supply chain; risks related to AI technology; our failure to manage our current leadership transitions; our failure to comply with the covenants under our credit agreement; our ability to remediate our material weaknesses in our internal control over financial reporting; our ability to comply with laws and regulations applicable to our business; our reliance on the experience and expertise of our senior management and other key personnel; our ability to adequately obtain, maintain, protect and enforce our intellectual property and proprietary rights; compliance with data privacy, data security, data protection and consumer protection laws and industry standards; risks associated with our brand and manufacturing partners; our reliance on third parties to provide payment processing infrastructure underlying our business; our dependence on online sources to attract consumers and promote our business which may be affected by third-party interference or cause our customer acquisition costs to rise; failure by us, our brand partners, or third party manufacturers to comply with our vendor code of conduct or other laws; risks related to our debt; our noncompliance with Nasdaq Marketplace Rule 5606(c)(2)(A), which requires listed companies to have at least three audit committee members; and risks related to our Class A capital stock and ownership structure.

Additional information regarding these and other risks and uncertainties that could cause actual results to differ materially from the expectations is included in our Quarterly Report on Form 10-Q for the quarter ended April 30, 2026, as will be updated in our Quarterly Report on Form 10-Q for the quarter ended July 31, 2026. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Key Business and Financial Metrics

Active Subscribers is defined as the number of subscribers with an active membership as of the last day of any given period and excludes paused subscribers. Total Subscribers represents the number of subscribers with an active or paused membership as of the last day of the period and excludes subscribers who had an active or paused subscription during the period, but ended their subscription prior to the last day of the fiscal period.

Average Active Subscribers is defined as the mean of the beginning of quarter and end of quarter Active Subscribers for a quarterly period; and for other periods, represents the mean of the Average Active Subscribers of every quarter within that period.

Gross Profit is defined as total revenue less costs related to activities to fulfill customer orders and rental product acquisition costs, presented as fulfillment and rental product depreciation and revenue share, respectively, on the consolidated statement of operations. We depreciate owned apparel assets over three years and owned accessory assets over two years, net of 20% and 30% salvage values, respectively, and recognize the depreciation on a straight-line basis and remaining cost of items when sold or retired on our consolidated statement of operations. Rental product depreciation expense is time-based and reflects all rental product items we own. We use Gross Profit and Gross Profit as a percentage of revenue, or Gross Margin, to measure the continued efficiency of our business after the cost of our products and fulfillment costs are included.

Non-GAAP Financial Measures

This press release and the accompanying tables contain the non-GAAP financial measures of Adjusted EBITDA, Adjusted EBITDA margin, free cash flow, and free cash flow margin. In addition to our results determined in accordance with GAAP, we believe that Adjusted EBITDA and Adjusted EBITDA margin are useful in evaluating our performance and free cash flow and free cash flow margin are useful in evaluating our performance and liquidity. Adjusted EBITDA is a key performance measure used by management to assess our operating performance and the operating leverage of our business prior to capital expenditures. These non-GAAP financial metrics are not meant to be considered as indicators of our financial performance in isolation from or as a substitute for our financial information prepared in accordance with GAAP and should be read only in conjunction with financial information presented on a GAAP basis. There are limitations to the use of the non-GAAP financial metrics presented in this press release. For example, our non-GAAP financial metrics may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial metrics differently than we do, limiting the usefulness of those measures for comparative purposes.

We define Adjusted EBITDA as net loss, adjusted to exclude interest expense, rental product depreciation, other depreciation and amortization, share-based compensation expense, write-off of liquidated assets, non-recurring adjustments, non-ordinary course legal fees, non-ordinary course executive transition costs, income tax (benefit) expense, other income and expense, and other gains / losses. Adjusted EBITDA margin is defined as Adjusted EBITDA calculated as a percentage of total revenue, net for a period.

We define free cash flow as net cash used in operating activities and net cash used in investing activities on a combined basis. Free cash flow margin is defined as free cash flow as a percentage of revenue.

The reconciliation of presented non-GAAP financial metrics to the most directly comparable GAAP financial measure is presented below. We encourage reviewing the reconciliation in conjunction with the presentation of the non-GAAP financial metrics for each of the periods presented. In future periods, we may exclude similar items, may incur income and expenses similar to these excluded items, and may include other expenses, costs and non-recurring items. Reconciliations of Adjusted EBITDA margin expectations for fiscal year 2026 and Q3 2026 to the most directly comparable GAAP measures are not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity, and low visibility with respect to the charges excluded from these non-GAAP measures, in particular, share-based compensation expense, and non-recurring expenses, which can have unpredictable fluctuations based on unforeseen activity that is out of our control and/or cannot reasonably be predicted.

Investor Contact
Investor Relations
investors@renttherunway.com

Media Contact
Press
press@renttherunway.com

Rent the Runway, Inc.
Condensed Consolidated Balance Sheets
(in millions)
(unaudited)
 
  July 31,   January 31,
    2026       2026  
Assets      
Current assets:      
Cash and cash equivalents $ 29.0     $ 50.4  
Restricted cash, current   4.0       4.5  
Prepaid expenses and other current assets   11.5       11.8  
Total current assets   44.5       66.7  
Restricted cash   4.2       4.2  
Rental product, net   84.1       86.0  
Fixed assets, net   22.9       24.0  
Intangible assets, net   1.9       2.0  
Operating lease right-of-use assets   27.5       29.3  
Other assets   7.3       8.8  
Total assets $ 192.4     $ 221.0  
Liabilities and Stockholders’ Equity (Deficit)      
Current liabilities:      
Accounts payable $ 4.4     $ 9.9  
Accrued expenses and other current liabilities   36.5       29.1  
Deferred revenue   13.0       12.0  
Customer credit and gift card liabilities   6.5       6.6  
Operating lease liabilities   5.7       5.6  
Total current liabilities   66.1       63.2  
Long-term debt, net   157.5       156.6  
Operating lease liabilities   32.8       35.7  
Other liabilities   1.5       1.6  
Total liabilities   257.9       257.1  
       
Stockholders’ equity (deficit)      
Class A common stock   —       —  
Class B common stock   —       —  
Preferred stock   —       —  
Additional paid-in capital   1,066.7       1,064.3  
Accumulated deficit   (1,132.2 )     (1,100.4 )
Total stockholders’ equity (deficit)   (65.5 )     (36.1 )
Total liabilities and stockholders’ equity (deficit) $ 192.4     $ 221.0  

Rent the Runway, Inc.
Condensed Consolidated Statements of Operations
(in millions, except share and per share amounts)
(unaudited)
 
  Three Months Ended July 31,   Six Months Ended July 31,
    2026       2025       2026       2025  
Revenue:              
Subscription and Reserve rental revenue $ 83.8     $ 69.2     $ 161.5     $ 131.2  
Other revenue   13.9       11.7       26.1       19.3  
Total revenue, net   97.7       80.9       187.6       150.5  
Costs and expenses:              
Fulfillment   23.5       22.5       47.1       42.9  
Technology   9.8       9.8       19.2       19.4  
Marketing   7.4       7.4       15.4       16.0  
General and administrative   23.8       24.6       47.2       45.3  
Rental product depreciation and revenue share   38.9       34.1       81.9       61.4  
Other depreciation and amortization   2.1       2.6       4.3       5.3  
Total costs and expenses   105.5       101.0       215.1       190.3  
Operating loss   (7.8 )     (20.1 )     (27.5 )     (39.8 )
Interest income / (expense), net   (0.2 )     (6.9 )     (0.5 )     (13.2 )
Other income / (expense), net   1.3       0.6       2.4       0.7  
Securities litigation expense   (6.1 )     —       (6.1 )     —  
Net loss before income tax benefit / (expense)   (12.8 )     (26.4 )     (31.7 )     (52.3 )
Income tax benefit / (expense)   (0.1 )     —       (0.1 )     (0.2 )
Net loss $ (12.9 )   $ (26.4 )   $ (31.8 )   $ (52.5 )
Net loss per share attributable to common stockholders, basic and diluted $ (0.38 )   $ (6.23 )   $ (0.95 )   $ (12.49 )
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted   33,576,091       4,237,890       33,501,272       4,203,550  

Rent the Runway, Inc.
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)
 
  Six Months Ended July 31,
    2026       2025  
OPERATING ACTIVITIES      
Net loss $ (31.8 )   $ (52.5 )
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Rental product depreciation and write-offs   20.8       21.6  
Write-off of rental product sold   7.7       7.5  
Other depreciation and amortization   4.3       5.3  
Proceeds from rental product sold   (13.3 )     (11.8 )
(Gain) / loss from liquidation of rental product   0.1       (0.4 )
Accrual of paid-in-kind interest   5.4       7.2  
Amortization of debt (premium) discount   (4.5 )     3.0  
Share-based compensation expense   2.2       2.9  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets   0.3       (3.2 )
Operating lease right-of-use assets   1.8       1.4  
Other assets   1.5       (1.2 )
Accounts payable, accrued expenses and other current liabilities   2.5       18.7  
Deferred revenue and customer credit liabilities   0.9       1.3  
Operating lease liabilities   (2.8 )     (2.2 )
Other liabilities   (0.1 )     0.2  
Net cash (used in) provided by operating activities   (5.0 )     (2.2 )
INVESTING ACTIVITIES      
Purchases of rental product   (27.7 )     (42.0 )
Proceeds from liquidation of rental product   0.8       1.6  
Proceeds from sale of rental product   13.3       11.8  
Purchases of fixed and intangible assets   (3.0 )     (2.1 )
Net cash (used in) provided by investing activities   (16.6 )     (30.7 )
FINANCING ACTIVITIES      
Proceeds from issuance of common stock   0.2       —  
Other financing payments   (0.5 )     (1.4 )
Net cash (used in) provided by financing activities   (0.3 )     (1.4 )
Net (decrease) increase in cash and cash equivalents and restricted cash   (21.9 )     (34.3 )
Cash and cash equivalents and restricted cash at beginning of period   59.1       86.5  
Cash and cash equivalents and restricted cash at end of period $ 37.2     $ 52.2  

Rent the Runway, Inc.
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)
 
  Six Months Ended July 31,
    2026     2025
Supplemental Cash Flow Information:      
Cash payments (receipts) for:      
Interest paid on loans $ 2.8   $ —
Fixed operating lease payments, net   5.9     5.7
Fixed assets and intangibles received in the prior period   0.2     —
Rental product received in the prior period   1.6     2.7
Non-cash financing and investing activities:      
Purchases of fixed assets and intangibles not yet settled $ 0.3   $ 0.1
Purchases of rental product not yet settled   1.4     4.4


Rent the Runway, Inc.

Reconciliation of GAAP to Non-GAAP Financial Measures
(in millions)
(unaudited)

The following table presents a reconciliation of net loss and net loss as a percentage of revenue, the most comparable GAAP financial measures, to Adjusted EBITDA and Adjusted EBITDA Margin, respectively, for the periods presented:

  Three Months Ended July 31,   Six Months Ended July 31,
    2026       2025       2026       2025  
  (in millions)   (in millions)
Net loss $ (12.9 )   $ (26.4 )   $ (31.8 )   $ (52.5 )
Interest (income) / expense, net(1)   0.2       6.9       0.5       13.2  
Rental product depreciation   14.7       15.9       28.5       29.1  
Other depreciation and amortization(2)   2.1       2.6       4.3       5.3  
Share-based compensation(3)   0.7       1.4       2.2       2.9  
Write-off of liquidated assets(4)   0.3       0.5       0.9       1.2  
Non-recurring adjustments(5)   —       2.0       0.1       2.0  
Non-ordinary course legal fees (6)   0.7       1.4       1.3       2.0  
Executive transition (7)   1.8       —       1.8       —  
Income tax (benefit) / expense   0.1       —       0.1       0.2  
Other (income) / expense, net(8)   (1.3 )     (0.6 )     (2.4 )     (0.7 )
Securities litigation expense   6.1       —       6.1       —  
Other (gains) / losses(9)   0.1       (0.1 )     0.2       (0.4 )
Adjusted EBITDA $ 12.6     $ 3.6     $ 11.8     $ 2.3  
Net Loss as a percentage of revenue (13.2)%   (32.6)%   (17.0)%   (34.9)%
Adjusted EBITDA Margin(10)   12.9 %     4.4 %     6.3 %     1.5 %


(1)   
Includes debt (premium) discount amortization of $(2.3) million in the three months ended July 31, 2026, $(3.9) million in the three months ended July 31, 2025, $(4.5) million in the six months ended July 31, 2026 and $3.0 million in the six months ended July 31, 2025.
(2)   Reflects non-rental product depreciation and capitalized software amortization.
(3)   Reflects the non-cash expense for share-based compensation.
(4)   Reflects the write-off of the remaining book value of liquidated rental product that had previously been held for sale.
(5)   Non-recurring adjustments for the three and six months ended July 31, 2026 includes none and $0.1 million of costs related to public company SOX readiness. Non-recurring adjustments for the three and six months ended July 31, 2025 includes $2.0 million of transaction related costs.
(6)   Non-ordinary course legal fees for the three and six months ended July 31, 2026 includes $0.7 million and $1.3 million of costs related to securities lawsuits and non-recurring legal fees. Non-ordinary course legal fees for the three and six months ended July 31, 2025 includes $1.4 million and $2.0 million of costs related to securities lawsuits and non-recurring legal fees including transaction related costs.
(7)   Executive transition for the three and six months ended July 31, 2026 includes $1.8 million of costs related to the transitions of the Chief Executive Officer and Executive Chair roles.
(8)   Includes other (income) / expense recognized in the period.
(9)   Includes gains / losses recognized in relation to foreign exchange, operating lease terminations and the related surrender of fixed assets (see “Note 4 – Leases – Lessee Accounting” in the Notes to the Condensed Consolidated Financial Statements).
(10)   Adjusted EBITDA Margin calculated as Adjusted EBITDA as a percentage of revenue.

Rent the Runway, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measures
(in millions)

The following table presents a reconciliation of net cash (used in) provided by operating activities, the most comparable GAAP financial measure, to Free Cash Flow and Free Cash Flow Margin for the periods presented:

    Six Months Ended July 31,
      2026       2025  
    (in millions)
Net cash (used in) provided by operating activities   $ (5.0 )   $ (2.2 )
Purchases of rental product     (27.7 )     (42.0 )
Proceeds from liquidation of rental product     0.8       1.6  
Proceeds from sale of rental product     13.3       11.8  
Purchases of fixed and intangible assets     (3.0 )     (2.1 )
Free Cash Flow   $ (21.6 )   $ (32.9 )
Free Cash Flow Margin   (11.5)%   (21.9)%

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.